Altair Joins Avicenna Alliance to Support Simulation-based Development of Medical Breakthroughs
“It’s time to take healthcare development into the digital age. We are excited about the opportunity to make a positive contribution to the work of the
Traditionally, development of new medicines and medical devices has involved extensive testing on people, and often included major investments in products that ultimately fail. Even when successful, the process is lengthy and expensive. In contrast, computer-based simulation facilitates intelligent use of historical data and early identification of the efficacy of proposed treatments. In addition, as a result of the work done by Altair and other members of the
Established in 2016, the alliance brings together stakeholders in industry, government, and academia to promote the benefits of ‘in silico’ medicine to overcome the prohibitive costs and delays often associated with conventional pharmaceutical trials, testing, and medical device development.
Altair will bring its expertise and experience in advanced simulation and data analytics to the pioneering work of the
“The need for faster development of innovative healthcare solutions has never been more apparent. We warmly welcome Altair as a new member of the
More information about the
About Altair (Nasdaq: ALTR)
Altair is a global technology company that provides software and cloud solutions in the areas of product development, high performance computing (HPC), and data analytics. Altair enables organizations across broad industry segments to compete more effectively in a connected world while creating a more sustainable future. To learn more, please visit www.altair.com.
|+49 7031 6208 0|
Source: Altair Engineering Inc.